BDBM511735 3-acetyl-1-(2-((2S,4R)-2-((6-bromopyridin-2- yl)carbamoyl)-4-fluoropyrrolidin-1-yl)-2- oxoethyl)-5-(2-methylpyrimidin-5-yl)-1H- indazole-7-carboxylic acid::US11084800, Cpd No. 41

SMILES CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2c(cc(cc12)-c1cnc(C)nc1)C(O)=O

InChI Key InChIKey=YUQKXQBEXPMMDL-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 511735   

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM511735(US11084800, Cpd No. 41 | 3-acetyl-1-(2-((2S,4R)-2-...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2022
Entry Details
US Patent